Baumann Andreas, Isak Daniel, Lohbeck Jasmin, Jagtap Pravin Kumar Ankush, Hennig Janosch, Miller Aubry K
Cancer Drug Development Group, German Cancer Research Center (DKFZ) Im Neuenheimer Feld 280 69120 Heidelberg Germany
Structural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL) 69117 Heidelberg Germany.
RSC Adv. 2022 Sep 21;12(41):26989-26993. doi: 10.1039/d2ra04670a. eCollection 2022 Sep 16.
Scalable asymmetric syntheses of two kallikrein-related protease 6 (KLK6) inhibitors are reported. The inhibitors are assembled by linking enantiomerically enriched fragments amide bond formation, followed by conversion of a cyano group to an amidine. One fragment, an amine, was prepared using the Ellman auxiliary, and a lack of clarity in the literature regarding the stereochemical outcome of this reaction was solved X-ray crystallographic analysis of two derivatives. Complexes of the inhibitors bound to human KLK6 were solved by X-ray crystallography, revealing the binding poses.
报道了两种激肽释放酶相关蛋白酶6(KLK6)抑制剂的可扩展不对称合成。这些抑制剂通过对映体富集片段的酰胺键形成进行组装,随后将氰基转化为脒。其中一个片段,即胺,是使用埃尔曼助剂制备的,通过对两种衍生物的X射线晶体学分析解决了文献中关于该反应立体化学结果的不明确之处。通过X射线晶体学解析了抑制剂与人KLK6结合的复合物,揭示了结合模式。